Yingzhong Lin

Huaqiao University — China

Immunology and Microbiology · Life Sciences

27h-index1.7kcitations94works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Atherosclerosis and Cardiovascular Diseases(26), Adipokines, Inflammation, and Metabolic Diseases(7), Aortic Disease and Treatment Approaches(7), Cytokine Signaling Pathways and Interactions(7), Cardiac Fibrosis and Remodeling(7)

Publications94 total

Expanding the Donor Pool without Compromising Outcomes: A Single Center Experience with Out-of-Sequence Kidney Allocation
American Journal of Transplantation·2025
Prevalence and prognostic impact of abnormal left ventricular ejection fraction in Hemodialysis patients with end-stage renal disease
BMC Nephrology·2025· 3 citedOpen Access
Integration of the hammerhead ribozyme into structured RNAs to measure ligand-binding events for riboswitch candidates and aptamers
Acta Biochimica et Biophysica Sinica·2025Open Access
Integration of the hammerhead ribozyme into structured RNAs to measure ligand-binding events for riboswitch candidates and aptamers
2025Open Access
Retraction notice to “Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK/macrophage/Fizz3 axis in mice” [Redox Biol. 36 (2020) 101636]
Redox Biology·2024Open Access
Kielin/chordin‐like protein deficiency aggravates pressure overload‐induced cardiac dysfunction and remodeling via <scp>P53</scp> / <scp>P21</scp> / <scp>CCNB1</scp> signaling in mice
The FASEB Journal·2024· 3 cited
Identification of potential therapeutic targets for coronary artery disease based on protein array and Mendelian Randomization analysis
European Heart Journal·2021Open Access
Left bundle branch pacing–optimized cardiac resynchronization therapy recovered heart failure in a patient with left ventricular noncompaction
HeartRhythm Case Reports·2021Open Access
Circulating IL‑37 levels are elevated in patients with hypertension
Experimental and Therapeutic Medicine·2021· 10 citedOpen Access
Corrigendum to “Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK/macrophage/Fizz3 axis in mice” [Redox Biol. 2020 36 101636]
Redox Biology·2020· 1 citedOpen Access
Effect of N-acetylcysteine on prevention of contrast-associated acute kidney injury in patients with STEMI undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomised controlled trials
BMJ Open·2020· 16 citedOpen Access
ADAMTS-5 Decreases in Aortas and Plasma From Aortic Dissection Patients and Alleviates Angiotensin II-Induced Smooth Muscle-Cell Apoptosis
Frontiers in Cardiovascular Medicine·2020· 13 citedOpen Access
IL-35 polymorphisms and cognitive decline did not show any association in patients with coronary heart disease over a 2-year period
Medicine·2020· 5 citedOpen Access
RETRACTED: Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK/macrophage/Fizz3 axis in mice
Redox Biology·2020· 35 citedOpen Access
A single-center observational study on the expression of circulating interleukin-20 levels and predicting outcomes in human chronic heart failure: A 2-year follow-up cohort study
Clinica Chimica Acta·2020· 12 cited
Circulating Sestrin Levels Are Increased in Hypertension Patients
Disease Markers·2020· 23 citedOpen Access
Interleukin‑22 is elevated in the atrium and plasma of patients with atrial fibrillation and increases collagen synthesis in transforming growth factor‑β1‑treated cardiac fibroblasts via the JNK pathway
Experimental and Therapeutic Medicine·2020· 5 citedOpen Access
The Expression of IL-12 Family Members in Patients with Hypertension and Its Association with the Occurrence of Carotid Atherosclerosis
Mediators of Inflammation·2020· 32 citedOpen Access
Roles and Mechanisms of Interleukin-12 Family Members in Cardiovascular Diseases: Opportunities and Challenges
Frontiers in Pharmacology·2020· 58 citedOpen Access
Anti‐interleukin‐5‐neutralizing antibody attenuates caradiac injury and cadiac dysfunction by aggravating the inflammatory response in doxorubicin‐treated mice
Cell Biology International·2020· 5 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Qingwei Ji(24), Ying Shi(24), Ling Liu(17), Tao Zeng(17), Zhen Wang(16), Lei Shi(15), Jun Wan(15), Menglong Wang(14), Yao Xu(14), Zicong Yang(14), Ying Huang(11), Di Ye(10), Huimin Jiang(9), Ling Liu(9), Yan Xue(9), Zhengde Lu(8), Qingwei Ji(7), Qiutang Zeng(6), Ying Huang(6), Yuan Wang(6)